Evidence-Based Guide

Medical Care in the US for Visitors From India

A physician's evidence-based guide for visitors from India: how to keep your Eltroxin, Amlong, Storvas, Glycomet, and Cardace regimen intact across a 9- to 10-hour flight, which of your prescriptions the US considers controlled substances, and what a US telehealth visit can and cannot do for the diaspora clinical pattern of early-onset diabetes and heart disease.

How can a visitor from India keep their prescriptions and chronic conditions on track during a US trip?

For the 2.2 million visitors who traveled from India to the US in 2024 (NTTO 2024), the two most common medical questions are how to keep a chronic-condition regimen intact and whether a foreign prescription can be filled here. The short answers are: your WHO INN generic names (levothyroxine, amlodipine, atorvastatin, metformin) are what a US pharmacist recognizes, not your Indian brand names; a US-licensed clinician must write any new US prescription; under the FDA Personal Importation Policy foreign nationals may bring a 90-day supply of their medications for personal use; and a same-day US telehealth visit can typically bridge non-controlled chronic medications (blood pressure, thyroid, oral diabetes, statins) for a stable visitor. Several drugs commonly prescribed in India are Schedule IV controlled substances in the US (Restyl / alprazolam, Modalert / modafinil, clonazepam, diazepam) and are governed by the DEA 50-dosage-unit personal-import rule (DEA 2026); some (Nitrosun / nitrazepam, Rohypnol / flunitrazepam) are not FDA-approved and cannot be prescribed in the US at all. For older visiting parents the clinical picture also matters: South Asians in the US have 23% age-adjusted diabetes prevalence compared with 6% in non-Hispanic Whites (Kanaya et al. 2014 MASALA/MESA study), diabetes is diagnosed about 10 years earlier (CDC 2015), and Asian Indian ancestry is now a formal "risk-enhancing factor" in the 2018 ACC/AHA cholesterol guidelines.
Medically reviewed by Parth Bhavsar, MD. Updated August 15, 2026.

Key Takeaways

  • India is now the 4th largest source of inbound US visitors, with 2.19 million arrivals in 2024, up 552 percent from 2020; over 5 million Indians hold a 10-year US visa. Medical questions from this population are common and specific.[1][2]
  • Your Indian prescription cannot be filled at a US pharmacy. A US-licensed clinician must write a new US prescription, and Indian brand names (Eltroxin, Amlong, Storvas, Cardace, Glycomet, Serlift, Restyl, Nitrosun) will not be recognized. Use the WHO INN generic name.[3]
  • Under the FDA Personal Importation Policy, foreign nationals may bring or ship a 90-day supply of drug products for personal use. Visitors staying longer can have additional supply mailed with proper documentation.[4]
  • Several medications commonly prescribed in India are DEA Schedule IV controlled substances in the US (alprazolam / Restyl, modafinil / Modalert, clonazepam, diazepam, zolpidem, tramadol) and follow the DEA 50-dosage-unit personal-import rule. Some (nitrazepam / Nitrosun, flunitrazepam / Rohypnol) are not FDA-approved and cannot be prescribed in the US.[5][6]
  • For visiting parents on insulin, the Delhi/Mumbai/Bangalore to US East Coast flight is a 9.5 to 10.5 hour westbound time-zone shift. Basal insulin is adjusted by approximately 4 percent per time zone crossed (about +38 to +42 percent on arrival day), then resumes home dose next day.[7]
  • The clinical picture matters for Indian visiting parents specifically: South Asians in the US have 23 percent age-adjusted diabetes prevalence versus 6 percent in non-Hispanic Whites (MASALA/MESA), diabetes is diagnosed about 10 years earlier (mean age 44.9 vs 55.4 in Whites), and the mean age of first myocardial infarction is 53 in South Asians vs 62-63 in Europeans/Chinese (INTERHEART).[8][9]
  • Asian Indian ancestry is a formal "risk-enhancing factor" in the 2018-2019 ACC/AHA Cholesterol and Primary Prevention Guidelines. WHO consensus BMI cutoffs for South Asians are lower (overweight >= 23, obesity >= 27.5) than the Western thresholds (>= 25 and >= 30).[10]
Editorial medical illustration: a warm nightstand still life with an Indian passport, a US boarding pass, four prescription pill bottles, a strip of Indian-style blister-packed tablets, a small brass Ayurvedic mortar and pestle, and a travel clock, representing a visitor from India managing chronic health during a US trip
An evidence-based guide for visitors from India to US medical care, from the TeleDirectMD medical team.

India is now the 4th largest source of overseas visitors to the US, with 2.19 million arrivals in 2024 and total spending near $20 billion in 2023.[1][11] Over 5 million Indians hold a 10-year US visitor visa, so the population coming into US primary and urgent care is not a thin edge case; it is the fastest-growing overseas source market and it comes with a distinct set of clinical and pharmaceutical questions.[11]

This guide supplements the broader pillar guide on medical care for international visitors and the two general satellites, Running Out of Medication in the US and Chronic Conditions While Your Parents Visit the US, with the India-specific version. The differences that actually matter are: (1) Indian brand names are not recognized by US pharmacists, (2) several commonly-prescribed Indian medications are DEA-controlled in the US, (3) the flight is a 9.5-10.5 hour westbound shift that changes insulin timing, and (4) the diaspora clinical pattern shifts the risk calculus for chronic disease management.

Why Your Indian Prescription Cannot Be Filled at a US Pharmacy

A US pharmacy requires a prescription from a US-licensed clinician. The clinician who wrote your original prescription in Delhi, Mumbai, Bangalore, Chennai, Hyderabad, Ahmedabad, or Kolkata is not licensed in the US, so the US pharmacy cannot fill their prescription even for an identical medication. This is federal and state law, not a paperwork technicality.[3]

Practically, this creates three issues:

  1. The Indian prescriber cannot legally prescribe in the US.
  2. The specific Indian brand may not exist in the US formulary, so the US clinician will substitute a US-approved equivalent identified by its generic (International Nonproprietary Name) name.[12]
  3. Some Indian medications are not FDA-approved and cannot be prescribed in any form in the US (discussed below).

The workaround is straightforward for a stable visitor on chronic non-controlled medications: a same-day US telehealth visit produces a US prescription that can be filled at any US pharmacy. Cash-pay pricing for generic amlodipine, lisinopril, losartan, metformin, levothyroxine, atorvastatin, and albuterol is typically $4 to $30 for a 30-day supply at Costco, Walmart, CVS, Walgreens, or Rite Aid with a GoodRx or similar discount. For most Indian visitors this is comparable to or lower than the retail cash price in India for the same generic manufactured by an Indian company (Cipla, Sun Pharma, Dr Reddy's, Torrent, Lupin, Aurobindo).

Mapping Common Indian Brand Names to US Equivalents

The single highest-yield thing you can do before traveling is write down your medications using their generic (WHO INN) names, not the Indian brand names. The WHO INN system exists precisely because "trade names vary widely" between countries, per the CDC Yellow Book.[12] Table 1 lists the most common chronic-condition medications prescribed in India and their US equivalents.

Table 1. Common Indian brand names, generic (INN) names, and US equivalents for chronic-condition medications.
Generic (INN) nameClass / useCommon Indian brand namesUS brand or generic
LevothyroxineThyroid hormone (hypothyroidism)Eltroxin, Thyronorm, Thyrox, ThyrofitSynthroid, Levoxyl, Unithroid, or generic levothyroxine
AmlodipineBlood pressure (calcium channel blocker)Amlong, Amlokind, Amlopres, Amlodac, StamloNorvasc or generic amlodipine
TelmisartanBlood pressure (ARB)Telma, Telsartan, Telpres, Telista, CresarMicardis or generic telmisartan
LosartanBlood pressure (ARB)Losar, Repace, Losacar, Tozaar, CozaarCozaar or generic losartan
RamiprilBlood pressure (ACE inhibitor)Cardace, Ramistar, Zorem, RamcorAltace or generic ramipril
MetoprololBlood pressure, heart rate (beta blocker)Metolar, Metpure, Betaloc, SelokeenLopressor, Toprol XL, or generic metoprolol
AtorvastatinCholesterol (statin)Storvas, Atorlip, Atocor, Atorva, LipitorLipitor or generic atorvastatin
RosuvastatinCholesterol (statin)Rosuvas, Rozavel, CrestorCrestor or generic rosuvastatin
MetforminType 2 diabetesGlycomet, Glucophage, Obimet, Gluformin, CetapinGlucophage or generic metformin (immediate or extended release)
GlimepirideType 2 diabetes (sulfonylurea)Amaryl, Glimestar, Glimulin, GlimyAmaryl or generic glimepiride
SitagliptinType 2 diabetes (DPP-4)Januvia, Istavel, ZitaJanuvia (brand only; no US generic)
SertralineSSRI (depression, anxiety)Serlift, Sertima, Zoloft, SertaZoloft or generic sertraline
EscitalopramSSRI (depression, anxiety)Nexito, S-Cital, Rexipra, Feliz-SLexapro or generic escitalopram
PantoprazoleAcid reflux, ulcer (PPI)Pantocid, Pantop, Pan, PantosecProtonix or generic pantoprazole
Aspirin (low-dose)Cardiovascular secondary preventionEcosprin, Loprin, AspicotBayer, Bufferin, or generic aspirin 81 mg
ClopidogrelAntiplateletClopilet, Ceruvin, Deplatt, ClopivasPlavix or generic clopidogrel
Albuterol (salbutamol INN)Asthma rescue inhalerAsthalin, Salbair, Ventorlin, VentolinProAir HFA, Ventolin HFA, Proventil HFA, or generic albuterol HFA

This is a partial list of the most commonly prescribed Indian brands. When in doubt, use the generic (INN) name; any US pharmacist and clinician will recognize it. For medications not on this list, refer to your original bottle or blister pack.

Indian brand to generic to US brand mapping Three-column table visual: common Indian brand names on the left, WHO INN generic names in the middle, and US brand or generic names on the right, for twelve common chronic-condition medications. Indian brand → generic (INN) → US brand The generic (WHO International Nonproprietary Name) is what a US clinician and pharmacist will recognize. Indian brand Generic (INN) US brand / generic Eltroxin, Thyronorm levothyroxine Synthroid / generic Amlong, Stamlo amlodipine Norvasc / generic Telma, Cresar telmisartan Micardis / generic Cardace, Ramistar ramipril Altace / generic Storvas, Atorlip atorvastatin Lipitor / generic Rosuvas, Rozavel rosuvastatin Crestor / generic Glycomet, Obimet metformin Glucophage / generic Amaryl, Glimestar glimepiride Amaryl / generic Serlift, Sertima sertraline Zoloft / generic Asthalin, Ventorlin salbutamol (albuterol INN) ProAir / Ventolin HFA Pantocid, Pan pantoprazole Protonix / generic Ecosprin, Loprin aspirin (81 mg) Bayer / generic Source: WHO INN system; Indian Pharmacopoeia Commission; FDA Orange Book; CDC Yellow Book 2026.
Common Indian brand names, WHO INN generic names, and US brand or generic equivalents for the most-prescribed chronic-condition medications.[12]

A few notes on gaps in this map:

  • Combiflam (ibuprofen 400 mg + paracetamol 325 mg fixed-dose combination) does not exist as a single US product. The US clinician will typically substitute with ibuprofen alone or acetaminophen alone, dosed separately.
  • Deriphyllin (theophylline + etophylline) is largely obsolete in US asthma and COPD care; substitute is inhaled corticosteroids, LABA, or LAMA depending on the indication.
  • Ayurvedic and traditional preparations are not FDA-approved and cannot be substituted. Continue them under the guidance of your home clinician; do not expect a US pharmacy to fill them.
  • Certain sustained-release or matrix formulations from Indian manufacturers (e.g., specific Zydus, Sun Pharma, or Cipla proprietary formulations) may not have a US bioequivalent; the US clinician will substitute the closest FDA-approved formulation, which may be a plain immediate-release or a different extended-release product.

The FDA 90-Day Rule for Foreign Nationals

Most Indian visitors have never heard about this and it prevents a lot of unnecessary trips to a US clinician. Under the FDA Personal Importation Policy, foreign nationals visiting the US may bring or ship a 90-day supply of their personal medication into the US.[4] Direct FDA quote: "The FDA will allow foreign nationals to bring or ship a 90-day supply of drug products," and "if the foreign national is staying longer than 90 days, they may have additional medication sent to them."[4]

Suggested documentation, per FDA guidance:[4]

  • A copy of the visa or passport
  • A letter from the treating physician in India
  • A copy of the prescription in English (Indian pharmacies routinely produce English prescriptions; ask for a printed one before you travel)

For visitors on complex or expensive regimens (biologics, specialty inhalers, insulin analogues, GLP-1 receptor agonists like semaglutide), planning the 90-day supply in advance is far cheaper than trying to fill an equivalent in the US. Many injectable diabetes and biologic medications cost several hundred to several thousand dollars per fill at US retail cash pricing.

DEA-Controlled Indian Brands and What Cannot Be Prescribed Here

Several medications routinely prescribed in India are Schedule IV controlled substances in the US, and a few are not FDA-approved at all. Bringing these into the US is governed by DEA rules, not the FDA personal-import rule. Per DEA guidance, foreign visitors may bring controlled substances into the US if the medication is in its original labeled container, the label includes the drug name and schedule symbol (or pharmacy or prescription number), the quantity does not exceed 50 dosage units per controlled substance, and the medication is declared to Customs and Border Protection at entry.[5]

Table 2 lists the most common Indian brands that fall into these categories.

Table 2. Common Indian brand medications that are DEA-controlled or not FDA-approved in the US.
Indian brandGeneric (INN)US statusPractical implication
Restyl, Alprax, AlprocontinAlprazolamSchedule IV controlled substance[6]DEA 50-dosage-unit personal-import rule applies. Most US telehealth companies decline to prescribe for new-patient visitors.
Clonotril, Lonazep, EpitrilClonazepamSchedule IV controlled substance[6]Same as alprazolam. Bring your supply; plan to use urgent care for a bridge if needed.
Modalert, Modvigil, Modaheal, Provigil (imported)ModafinilSchedule IV controlled substance[13]DEA 50-dosage-unit rule applies. US telehealth will typically not bridge for a new-patient visitor.
Zolfresh, Nitrest, Ambien (imported)ZolpidemSchedule IV controlled substance[6]Same as above.
Ultracet, Tramazac, Tramadol IHTramadolSchedule IV controlled substance[6]DEA 50-dosage-unit rule applies.
Diazepam, Valium (imported), CalmposeDiazepamSchedule IV controlled substance[6]DEA 50-dosage-unit rule applies.
Nitrosun, Nitrazep, SedamonNitrazepamNot FDA-approvedCannot be prescribed in the US. Substitute is typically lorazepam or temazepam via a US-licensed clinician.
Rohypnol (rarely prescribed in India, but sold in some markets)FlunitrazepamNot FDA-approved in the US[14]Cannot be prescribed in the US. Rohypnol has never had FDA approval; DEA classifies it as Schedule IV but importation for personal use is very restricted.
Codeine syrups (Corex, Phensedyl, various)Codeine + antihistamine combinationsSchedule V or Schedule III depending on formulationMost codeine cough syrups sold OTC in India are prescription-only in the US. Do not assume home OTC status transfers.

Cannabis products remain federally illegal in the US regardless of home-country status. Ayurvedic preparations containing controlled or non-FDA-approved ingredients may be seized at entry. All medications must be declared to Customs and Border Protection at entry.

The practical takeaway for a visitor on any of the Schedule IV medications above: bring your supply, use the DEA 50-dosage-unit personal-import rule, and expect that if you run out unexpectedly the path is urgent care or a walk-in clinic, not telehealth. DEA telemedicine flexibilities extended through December 31, 2026 technically allow US clinicians to prescribe Schedule II-V controlled medications via audio-video telemedicine without a prior in-person exam, but most US telehealth companies apply stricter internal rules and decline controlled prescriptions for new-patient visitors.[15]

Insulin and Time-Zone Dosing on the India to US Flight

The Delhi, Mumbai, Bangalore, Chennai, or Hyderabad to US flight is one of the most extreme time-zone shifts most Indian visitors will make. India Standard Time (IST) is UTC+5:30. US Eastern Time is UTC-5 (or UTC-4 during daylight saving), which means India to US East Coast is a 9.5 to 10.5 hour westbound shift. India to US Central is 10.5 to 11.5 hours; India to US West Coast is 12.5 to 13.5 hours. All three are westbound (longer day) trips.

For patients on insulin, the widely used practical rule from the 2021 Diabetes/Metabolism Research and Reviews review by Forst and colleagues is that basal insulin doses are adjusted by approximately 4 percent per time zone crossed. Westbound travel lengthens the day and typically requires more insulin on the arrival day; eastbound (return) shortens the day and requires less.[7]

Basal insulin dose adjustment for India to US flights Horizontal bar chart showing arrival-day basal insulin dose adjustments for six common India to US travel corridors using the 4 percent per time zone rule. All are westbound (longer day) trips requiring a temporary dose increase. Basal insulin: arrival-day adjustment, India to US flights All India to US routes are westbound (longer day). Rule of thumb: ~4% dose change per time zone crossed. +10% +20% +30% +40% +50% +60% 0% +42% Delhi → New York Westbound, 10.5 h +38% Mumbai → Newark Westbound, 9.5 h +42% Bangalore → Atlanta Westbound, 10.5 h +46% Chennai → Chicago Westbound, 11.5 h +46% Hyderabad → Dallas Westbound, 11.5 h +54% Delhi → San Francisco Westbound, 13.5 h On the day of arrival only. Resume home dose the following day. Applies when: (a) time-zone shift ≥5 h, AND (b) staying ≥3 days at destination. Source: Forst et al. 2021 Diabetes Metab Res Rev. Not a substitute for the home endocrinologist’s plan.
Arrival-day basal insulin dose adjustment for six common India to US flight routes, using the 4 percent per time-zone rule.[7]

For most Indian visitors this works out to a single-day basal insulin adjustment on arrival, then resuming the normal home dose the following day. Any patient on complex insulin regimens or an insulin pump should get a personalized time-zone plan from their endocrinologist in India before departure.

For the return leg (US to India, eastbound), the day shortens and basal insulin doses are reduced by the same 4 percent per hour on the day of arrival back home. Consider skipping one basal dose if the return leg is 9 hours or more.

For a fuller decision framework covering oral daily medications, levothyroxine bedtime dosing, and jet-lag-versus-warning-signs, see the companion satellite, Chronic Conditions While Your Parents Visit the US.

Why the Diaspora Clinical Picture Matters for Visiting Parents

Two related patterns in the South Asian population change the risk calculus in ways worth knowing when planning a US visit for an older parent.

Diabetes: earlier onset, higher prevalence, lower BMI threshold. The Mediators of Atherosclerosis in South Asians Living in America (MASALA) study, comparing 906 South Asian adults to matched participants in the Multi-Ethnic Study of Atherosclerosis (MESA), found an age-adjusted type 2 diabetes prevalence of 23 percent in South Asians compared with 6 percent in non-Hispanic Whites, 18 percent in African Americans, 17 percent in Latinos, and 13 percent in Chinese Americans (Kanaya et al., Diabetes Care 2014).[8] CDC data show that South Asians are diagnosed with diabetes at a mean age of 44.9 years compared with 55.4 in non-Hispanic Whites, approximately a decade earlier.[9]

The WHO/Asian consensus BMI cutoffs for South Asians are lower than the Western thresholds: overweight is BMI >= 23 kg/m2 (Western threshold: 25), and obesity is BMI >= 27.5 kg/m2 (Western threshold: 30).[16] A South Asian visitor with a BMI of 24 who would be "normal" by US charts is by consensus at increased cardiometabolic risk.

Atherosclerotic cardiovascular disease: earlier onset, higher rates. The 2018-2019 ACC/AHA Cholesterol and Primary Prevention Guidelines formally recognize South Asian ancestry as a "risk-enhancing factor."[10] The INTERHEART study found the mean age of first myocardial infarction in South Asians is 53 years, compared with 62 to 63 in Europeans and Chinese.[17] Analysis of US mortality data from 2003 to 2017 showed Asian Indians (men and women) have the highest age-standardized mortality rates from ischemic heart disease among all US races and ethnicities, and Asian Indian is the only US race/ethnicity for which that rate has been rising since 2011.[17]

The practical implication for a visiting parent: symptoms that might be dismissed as jet lag or reflux in a lower-risk group deserve more prompt evaluation in a South Asian visitor. New chest discomfort, exertional shortness of breath, or upper-abdominal pressure warrants a same-day US urgent care or ER visit, not a wait-and-see. This is the same message the American College of Cardiology has been sending to primary-care clinicians treating South Asian patients since 2018.

What US Telehealth Can Bridge for an Indian Visitor

For non-controlled chronic medications, a single physician-led US telehealth visit typically produces a same-day US prescription for a 30-day bridge supply. Cash-pay pricing for the visit is $50 to $150; the generic medication at a US pharmacy with GoodRx or similar discount is typically $4 to $30 for a 30-day supply.

Common chronic medications a US telehealth clinician can typically bridge for a stable Indian visitor:

  • Blood pressure: amlodipine (from Amlong, Stamlo), telmisartan (from Telma, Cresar), losartan (from Losar, Repace), ramipril (from Cardace), metoprolol (from Metpure, Betaloc).
  • Thyroid: levothyroxine (from Eltroxin, Thyronorm).
  • Type 2 diabetes: metformin (from Glycomet), glimepiride (from Amaryl, Glimestar), sitagliptin (from Istavel, Zita), empagliflozin (from Jardiance), dapagliflozin.
  • Statins: atorvastatin (from Storvas, Atorlip), rosuvastatin (from Rosuvas, Crestor).
  • SSRIs and SNRIs: sertraline (from Serlift), escitalopram (from Nexito, S-Cital), fluoxetine, duloxetine.
  • Asthma: albuterol inhalers (from Asthalin, Ventorlin), inhaled corticosteroids, and ICS-LABA combinations.
  • Antiplatelet: aspirin 81 mg (from Ecosprin), clopidogrel (from Clopilet).
  • GI: pantoprazole (from Pantocid), omeprazole (from Omez).

For a broader review of what US telehealth cannot bridge (biologics, warfarin, controlled substances for new-patient visitors, pregnancy-related medication questions, pediatric fever in an infant), see the sister satellite, Running Out of Medication in the US.

Visa and Insurance Reality

Almost no visitor from India has US health insurance. The common visa categories that Indian visitors travel on, and what they do and do not include:

  • B1/B2 visitor visa (business or tourism, up to 10-year multi-entry): confers no US insurance benefit. Cash pay or visitor insurance is the only option.
  • F2 dependent visa (spouse or child of an F1 student): confers no US insurance benefit; some US universities offer optional dependent coverage but this is not automatic.
  • H4 dependent visa (spouse or child of H1B worker): may be covered under the H1B worker's US employer health plan if the plan permits dependent enrollment; often is. Verify with the H1B worker's HR before travel.
  • J2 dependent visa (spouse or child of J1 exchange visitor): the primary J1 visa requires a health insurance policy that meets specific criteria; J2 dependents are typically included, but this should be verified.

US Medicare does not cover foreign visitors regardless of age, and there is no US-India reciprocal healthcare agreement. Short-term visitor insurance from providers such as ICICI Lombard, HDFC ERGO, Bajaj Allianz, TATA AIG, or US-based options (Trawick International, IMG, Seven Corners, Atlas America) typically costs $2 to $8 per day for a healthy visitor and covers acute illness at typical urgent care and hospital rates.

For a stable chronic-condition visit that is really a routine bridge prescription, cash-pay telehealth ($50 to $150) plus a generic medication ($4 to $30) is often the cheapest option regardless of insurance status.

What to Bring to a US Telehealth or Urgent Care Visit

Preparation is what turns a US visit into a same-day success rather than a two-visit process.

  • A written medication list in English using generic (INN) names, with doses and frequency (for example, "amlodipine 5 mg once daily," not "Amlong 5 morning").
  • Original medication strips or bottles with legible Indian pharmacy labels, so the US clinician can confirm the exact formulation and manufacturer.
  • A doctor's letter from your Indian clinician listing your diagnoses, allergies, blood type, and current medications, ideally on clinic letterhead. This substantially shortens a US visit and is invaluable if you end up needing urgent care.
  • Recent labs if you have them: HbA1c and fasting glucose (for diabetes), TSH (for thyroid), lipid panel (for statin), INR (for warfarin), recent BP log (for hypertension).
  • The name and phone number of a US pharmacy near where you are staying. CVS, Walgreens, Costco, Walmart, and Rite Aid are widely available and accept GoodRx discount cards.

Language is rarely a barrier: most US telehealth clinicians speak English, and many US urgent care and hospital settings offer language interpretation services under federal Section 1557 of the Affordable Care Act at any facility that receives federal funding, which is essentially every US hospital.

When to Skip Telehealth and Go In Person

Bridge prescriptions are for stable visitors with no new symptoms. Given the South Asian clinical picture, the threshold for in-person US care should be lower than it might be for a lower-risk group. Go to a US urgent care, emergency department, or call 911 if any of the following:

  • New chest pain, pressure, tightness, or exertional shortness of breath. This is a 911 call in a South Asian adult over 40, regardless of pre-existing risk assessment.
  • New unilateral weakness, facial droop, or slurred speech. This is a 911 call. Use the FAST protocol: Face, Arms, Speech, Time.
  • Severe headache, worst of life, or with neurological symptoms. ER.
  • Signs of a heart failure exacerbation: orthopnea, ankle swelling with weight gain, dyspnea at rest. ER or same-day urgent care.
  • Unilateral calf swelling, warmth, or tenderness after the flight. Same-day urgent care for DVT evaluation. The 15-hour Delhi to San Francisco flight is exactly the kind of long-haul journey that raises VTE risk.
  • Uncontrolled diabetes: persistent fingerstick glucose over 250 mg/dL, symptomatic hypoglycemia, or ketones. Urgent care or ER.
  • New fever with confusion or hypotension in an older visitor. ER.
  • Fall with head injury or possible fracture. ER.

For the general framework of when to use 911 vs ER vs urgent care vs telehealth for an international visitor, see the parent guide, Medical Care for International Visitors.

Frequently Asked Questions

No. US pharmacies require a prescription from a US-licensed clinician. A same-day physician-led telehealth visit is usually the fastest way to obtain a new US prescription for a chronic non-controlled Indian medication you already take. Bring a written list of your medications using generic (WHO INN) names.

Under the FDA Personal Importation Policy, foreign nationals may bring or ship a 90-day supply of their personal medication into the US. Visitors staying longer than 90 days may have additional medication sent to them. Suggested documentation includes a copy of your visa or passport, a doctor's letter from your Indian clinician, and a copy of the prescription in English.

Yes, but under DEA rules, not the FDA rule. Foreign visitors may bring up to 50 dosage units per controlled substance for personal use, in the original labeled container that includes the drug name and schedule symbol (or pharmacy and prescription number). Declare all medications to Customs and Border Protection at entry. Alprazolam (Restyl), modafinil (Modalert), clonazepam, diazepam, zolpidem, and tramadol are all DEA Schedule IV controlled substances in the US.

Nitrazepam (sold as Nitrosun, Nitrazep, or Sedamon) is not FDA-approved and cannot be prescribed in the US. Rohypnol (flunitrazepam) has never had FDA approval. Cannabis products remain federally illegal in the US regardless of home-country legal status. Certain Ayurvedic preparations containing heavy metals or non-FDA-approved active ingredients may be seized at entry.

For a Delhi/Mumbai/Bangalore to US East Coast flight (9.5 to 10.5 hours westbound), basal insulin is adjusted by approximately 4 percent per time zone crossed, or about plus 38 to 42 percent on the day of arrival. Resume your normal home dose the following day. Any patient on complex insulin regimens or an insulin pump should get a personalized plan from their endocrinologist in India before travel.

There is no direct US equivalent because Combiflam is a fixed-dose combination of ibuprofen 400 mg and paracetamol (acetaminophen) 325 mg, and this combination is not sold as a single product in the US. The US substitute is ibuprofen and acetaminophen taken separately at appropriate doses; both are available OTC. Ask your US clinician if you want a prescription-strength version.

No. US Medicare covers US citizens and lawful permanent residents (Green Card holders with 40 quarters of qualifying work history in most cases); it does not cover foreign visitors regardless of age. B1/B2, F2, H4, and J2 visitors are not eligible. Options are cash pay or visitor insurance from Indian providers (ICICI Lombard, HDFC ERGO, Bajaj Allianz, TATA AIG) or US-based short-term travel policies (Trawick, IMG, Seven Corners, Atlas America), typically $2 to $8 per day for a healthy visitor.

In a South Asian visitor over 40, new chest pain, pressure, or exertional shortness of breath should not be assumed to be jet lag. The mean age of first myocardial infarction in South Asians is 53, compared with 62 to 63 in Europeans and Chinese, and Asian Indians in the US have the highest age-standardized ischemic heart disease mortality rate among US races and ethnicities. Call 911 or go to the nearest ER. Do not wait to see if it improves.

Possibly, if the H1B worker's US employer offers dependent coverage and the H4 spouse is enrolled. This is not automatic; verify with the H1B worker's HR before your visit or expect to be uninsured. Cash-pay telehealth for a routine bridge prescription is typically $50 to $150 and often the most practical option regardless.

References

  1. U.S. Department of Commerce, National Travel and Tourism Office. Survey of International Air Travelers, Results 2024. Available at https://www.trade.gov/feature-article/survey-international-air-travelers-results-2024.
  2. U.S. Department of Commerce, National Travel and Tourism Office. International Visitor Forecast, March 2025. Available at https://www.trade.gov/sites/default/files/2025-03/2025-Forecast-Summary.pdf.
  3. U.S. Food and Drug Administration. Traveling with Prescription Medications. FDA Drug Info Rounds. Available at https://www.fda.gov/drugs/fda-drug-info-rounds-video/traveling-prescription-medications.
  4. U.S. Food and Drug Administration. Personal Importation. Available at https://www.fda.gov/industry/import-basics/personal-importation.
  5. U.S. Drug Enforcement Administration. Traveling to the U.S. with Medication. Available at https://www.dea.gov/sites/default/files/2026-05/Traveling%20With%20Medication_5.pdf.
  6. U.S. Drug Enforcement Administration. Drug Scheduling. Available at https://www.dea.gov/drug-information/drug-scheduling.
  7. Forst T, Choudhary P, Schneider D, Linetzky B, Pozzilli P. A practical approach to the clinical challenges in initiation of basal insulin therapy in people with type 2 diabetes. Diabetes Metab Res Rev. 2021;37(6):e3418. Available at https://pmc.ncbi.nlm.nih.gov/articles/PMC8519070/.
  8. Kanaya AM, Herrington D, Vittinghoff E, Ewing SK, Liu K, Blaha MJ, et al. Understanding the high prevalence of diabetes in U.S. South Asians compared with four racial/ethnic groups: the MASALA and MESA studies. Diabetes Care. 2014;37(6):1621-1628. Available at https://pubmed.ncbi.nlm.nih.gov/24705613/.
  9. Becerra MB, Becerra BJ. Disparities in Age at Diabetes Diagnosis Among Asian Americans: Implications for Early Preventive Measures. Prev Chronic Dis. 2015;12:150006. Available at https://www.cdc.gov/pcd/issues/2015/15_0006.htm.
  10. Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol. Circulation. 2019;139(25):e1082-e1143. Available at https://pubmed.ncbi.nlm.nih.gov/30586774/.
  11. U.S. International Trade Administration. India, Travel and Tourism. Country Commercial Guides. Available at https://www.trade.gov/country-commercial-guides/india-travel-and-tourism.
  12. Centers for Disease Control and Prevention. Travelers with Chronic Illnesses. CDC Yellow Book 2026. Available at https://www.cdc.gov/yellow-book/hcp/travelers-with-additional-considerations/travelers-with-chronic-illnesses.html.
  13. U.S. Food and Drug Administration. PROVIGIL (modafinil) Tablets [C-IV] label. Available at https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020717s037s038lbl.pdf.
  14. U.S. Drug Enforcement Administration. Rohypnol Drug Fact Sheet. Available at https://www.dea.gov/factsheets/rohypnol.
  15. U.S. Drug Enforcement Administration. DEA Extends Telemedicine Flexibilities to Ensure Continued Access to Care. December 31, 2025. Available at https://www.dea.gov/press-releases/2025/12/31/dea-extends-telemedicine-flexibilities-ensure-continued-access-care.
  16. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363(9403):157-163. Available at https://pubmed.ncbi.nlm.nih.gov/14726171/.
  17. Volgman AS, Palaniappan LS, Aggarwal NT, Gupta M, Khandelwal A, Krishnan AV, et al. Atherosclerotic Cardiovascular Disease in South Asians in the United States: Epidemiology, Risk Factors, and Treatments: A Scientific Statement From the American Heart Association. Circulation. 2018;138(1):e1-e34. Available at https://pubmed.ncbi.nlm.nih.gov/29794080/.